Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated just now
Peer-reviewedCC BY 4.0Cureus

Improving Timely Antibiotic Administration in Febrile Neutropenia: A Quality Improvement Initiative in a Tertiary Oncology Hospital

  1. 1Medical Oncology, Amrita Institute of Medical Sciences and Research Centre, Faridabad, IND
  2. 2Hematology, Amrita Institute of Medical Sciences and Research Centre, Faridabad, IND

Abstract

Background: Febrile neutropenia (FN) is an oncological emergency in which delays in the administration of empiric broad-spectrum antibiotics can increase the risk of sepsis and other serious complications.

Aim: This study aimed to reduce the median time from fever recognition to first-dose administration of empiric intravenous antibiotics to less than 60 minutes in adult oncology patients with FN presenting to the emergency department (ED) or inpatient department (IPD) of a tertiary oncology hospital.

Methods: This single-centre quality improvement (QI) study employed a prospective Plan-Do-Study-Act (PDSA) approach over six months in the ED and inpatient oncology ward of Amrita Institute of Medical Sciences, Faridabad, India. Oncology patients with fever and neutropenia were included, with 26 patients evaluated in each cycle. The intervention bundle comprised standardization of the FN definition and care pathway, triage prioritization of suspected FN, staff education, fever-alert chart flags, rapid clinician notification, streamlined antibiotic ordering and administration, vascular access escalation planning, and improved ward-level antibiotic availability. The primary process measure was median time from fever recognition to first-dose empiric intravenous antibiotic administration; the proportion of patients receiving antibiotics within 60 minutes was also assessed. Patients with missing or erroneous antibiotic-administration timestamps were excluded from these timeliness calculations but retained in the enrolled cohort used for all other measures.

Results: In the baseline cycle, the median time to antibiotic administration was 57.5 minutes, with 50% of patients receiving antibiotics within 60 minutes among those with valid time records; documentation errors were present in six of 26 cases. Following implementation of the intervention bundle, the median time decreased to 39.5 minutes in Cycle 2 and 39 minutes in Cycle 3, while the proportion treated within 60 minutes improved to 83.3% and 84%, respectively. Documentation quality also improved, with incomplete or erroneous time records decreasing from six cases at baseline to two in Cycle 2 and one in Cycle 3.

Conclusion: A structured, low-cost, multidisciplinary QI intervention was associated with faster and more reliable administration of empiric antibiotics in adult patients with FN. This project supports the use of PDSA-based workflow redesign, staff education, and rapid-alert systems to improve adherence to the 60-minute antibiotic target in routine oncology practice.

Related

  1. The golden hour: the feasibility of a quality improvement project to decrease the time to antibiotic administration in children with cancer and febrile neutropenia in Jordan
    Hadeel Halalsheh, Ghada Abu Alrub, Islam Kallab +6
    Frontiers in pediatricsPeer-reviewedCC BYFull textOncologyEurope PMCEurope PMCPMC
  2. Improving rational medicine prescribing at a public district hospital in southwestern Uganda, January-November 2021: a quality improvement initiative
    R. Migisha, S. Namasambi, B. Kwesiga +2
    medRxivPreprintCC BYFull textEpidemiology & public healthmedRxiv
  3. Improving Blood Pressure Control Post Emergency Department Visit Through Structured Patient Education and Telephone Follow-up: A Quality Improvement Initiative
    M. Aqeel, M. Hashmi, U. Shoaib +2
    medRxivPreprintCC BYFull textEpidemiology & public healthmedRxiv
  4. Improving surgical antibiotic prophylaxis in obstetric and gynaecological surgery: a prospective two-cycle quality-improvement clinical audit in a North African tertiary hospital.
    Ikram Hajjar, Fatma Sellami, Mariem Znati +9
    Infection prevention in practicePeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  5. Successful Alternate-day Osimertinib Administration with Desensitization Following Osimertinib-induced Hepatotoxicity and Neutropenia in a Case of EGFR-mutant Lung Cancer
    Tatsuo Furuya, Satoru Okada, Masanori Shimomura +2
    Internal MedicinePeer-reviewedCC BY-NC-NDFull text1 citedGeneral medicineJ-STAGE
BibTeX
@article{dalain2026improving,
  title = {{Improving Timely Antibiotic Administration in Febrile Neutropenia: A Quality Improvement Initiative in a Tertiary Oncology Hospital}},
  author = {Gaurav Dalain and Vidit Kapoor and Prashant Mehta and Anshul Jain and Saphalta Baghmar and Pravas Mishra},
  journal = {Cureus},
  year = {2026},
  month = oct,
  doi = {10.7759/cureus.117668},
  url = {https://doi.org/10.7759/cureus.117668},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Improving Timely Antibiotic Administration in Febrile Neutropenia: A Quality Improvement Initiative in a Tertiary Oncology Hospital
AU  - Gaurav Dalain
AU  - Vidit Kapoor
AU  - Prashant Mehta
AU  - Anshul Jain
AU  - Saphalta Baghmar
AU  - Pravas Mishra
PY  - 2026
DA  - 2026/10/09
JO  - Cureus
DO  - 10.7759/cureus.117668
UR  - https://doi.org/10.7759/cureus.117668
AB  - Background: Febrile neutropenia (FN) is an oncological emergency in which delays in the administration of empiric broad-spectrum antibiotics can increase the risk of sepsis and other serious complications.  Aim: This study aimed to reduce the median time from fever recognition to first-dose administration of empiric intravenous antibiotics to less than 60 minutes in adult oncology patients with FN presenting to the emergency department (ED) or inpatient department (IPD) of a tertiary oncology hospital.  Methods: This single-centre quality improvement (QI) study employed a prospective Plan-Do-Study-Act (PDSA) approach over six months in the ED and inpatient oncology ward of Amrita Institute of Medical Sciences, Faridabad, India. Oncology patients with fever and neutropenia were included, with 26 patients evaluated in each cycle. The intervention bundle comprised standardization of the FN definition and care pathway, triage prioritization of suspected FN, staff education, fever-alert chart flags, rapid clinician notification, streamlined antibiotic ordering and administration, vascular access escalation planning, and improved ward-level antibiotic availability. The primary process measure was median time from fever recognition to first-dose empiric intravenous antibiotic administration; the proportion of patients receiving antibiotics within 60 minutes was also assessed. Patients with missing or erroneous antibiotic-administration timestamps were excluded from these timeliness calculations but retained in the enrolled cohort used for all other measures.  Results: In the baseline cycle, the median time to antibiotic administration was 57.5 minutes, with 50% of patients receiving antibiotics within 60 minutes among those with valid time records; documentation errors were present in six of 26 cases. Following implementation of the intervention bundle, the median time decreased to 39.5 minutes in Cycle 2 and 39 minutes in Cycle 3, while the proportion treated within 60 minutes improved to 83.3% and 84%, respectively. Documentation quality also improved, with incomplete or erroneous time records decreasing from six cases at baseline to two in Cycle 2 and one in Cycle 3.  Conclusion: A structured, low-cost, multidisciplinary QI intervention was associated with faster and more reliable administration of empiric antibiotics in adult patients with FN. This project supports the use of PDSA-based workflow redesign, staff education, and rapid-alert systems to improve adherence to the 60-minute antibiotic target in routine oncology practice.
SN  - 2168-8184
ER  -